2013
DOI: 10.1016/j.ramb.2012.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Postmenopausal osteoporosis, breast cancer, and aromatase inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…Osteoporosis is a systemic skeletal disease characterized by low bone mass, deterioration in the microarchitecture, quality of bone tissue, and decreased bone strength leading to an increased risk of fracture 5 . Postmenopausal osteoporosis is an important public health disease.…”
Section: Introductionmentioning
confidence: 99%
“…Osteoporosis is a systemic skeletal disease characterized by low bone mass, deterioration in the microarchitecture, quality of bone tissue, and decreased bone strength leading to an increased risk of fracture 5 . Postmenopausal osteoporosis is an important public health disease.…”
Section: Introductionmentioning
confidence: 99%